• SENSEX 73,123.83
    -125.56 (--0.17%)
  • BANKNIFTY 54,287.35
    -638.35 (--1.16%)
  • SBI
    950.75 900.80(%)
  • Tonbo Imaging
    1,209.85 1,209.85(%)
  • Cyient
    1,268.00 1,268.00(%)
  • NSE
    1,640.25 1,640.25(%)
  • Bonfiglioli Tran
    527.40 527.40(%)
  • IndusInd Bank
    831.35 750.45(%)
  • Eternal
    317.50 344.75(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 940.00(%)
  • Swiggy
    174.90 174.90(%)
  • Persistent Systems
    5,688.80 4,242.65(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,003.65(%)
  • PC Jeweller
    17.08 7.45(%)
  • Bharat Forge
    1,680.45 1,265.00(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vivo Bio Tech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3920.0
  • ISIN : INE380K01017
12.93 -2 (-12.04%)
  • As on 25 Oct 2026 (EOD)

  • Today’s Low

    12.07

  • Today’s High

    14.77

  • Open

    14.70

  • Perv Close

    14.70

  • 52W Low

    12.07

  • 52W High

    20.94

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    28.69

  • Div & Yield %

    0.00

  • Book Value(₹)

    41.28

  • Debt-Equity Ratio

    -12.04

  • AGM Date

    23-Oct-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    1.27

  • Mar.Cap (₹Cr.)

    28.69

  • RONW (%)

    4.76

  • ROCE (%)

    9.88

Score Board

  • Equity (₹ in Cr.)

    22.19

  • BV (₹)

    41.30

  • Sales( ₹ in Cr.)

    52.57

  • NP (in Cr.)

    -2.19

  • NP Var(%)

    -216.0

  • Div%

    0.0

  • CPS (₹)

    3.80

  • EPS (₹)

    -1.00

  • Traded Value (₹ in Lakhs)

    28.18

  • 52 Week High

    20.94

  • 52 Week Low

    12.07

  • Price BSE

    13.0

  • Price NSE

    13.00

  • Market Capital( in Cr.)

    28.18

  • P/C Ratio

    3.40

  • P/E Ratio

    -13.20

  • Price Vs.BV

    -1.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 52.57 46.67 44.88 51.62 51.39 51.78
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 52.57 46.67 44.88 51.62 51.39 51.78
Other Income 0.44 4.80 0.04 0.04 0.09 0.08
Stock Adjustments 0.36 -0.98 0.80 -1.84 -3.47 2.70
Total Income 53.37 50.49 45.72 49.82 48.01 54.56
EXPENDITURE :            
Raw Materials 8.49 4.81 4.65 4.93 7.97 9.91
Power and Fuel Cost 3.20 3.28 3.93 4.27 3.56 5.78
Employee Cost 15.95 11.86 10.13 13.15 9.42 8.57
Other Manufacturing Expenses 2.02 2.07 1.69 2.56 3.03 1.42
Selling and Administration Expenses 1.98 2.82 4.00 3.05 7.76 11.02
Miscellaneous Expenses 0.60 0.00 0.02 0.00 0.10 -0.02
Employee Benefit Expenses 15.95 11.86 10.13 13.15 9.42 8.57
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 32.25 24.85 24.43 27.96 31.83 36.67
Operating Profit 21.12 25.65 21.30 21.86 16.18 17.88
Interest 5.91 7.55 7.95 7.99 4.27 3.67
Gross Profit 15.21 18.10 13.35 13.87 11.91 14.21
Depreciation 10.63 9.02 9.29 9.27 7.44 5.59
Profit Before Tax 4.58 9.08 4.06 4.60 4.47 8.62
Current Tax 0.81 2.08 1.68 1.03 0.76 1.36
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 5.71 -0.57 -0.14 0.94 1.51 1.58
Reported Net Profit -1.94 7.57 2.52 2.63 2.20 5.68
Extraordinary Items 0.26 5.67 0.00 0.00 0.00 0.00
Adjusted Net Profit -2.20 1.90 2.52 2.63 2.20 5.68
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 29.08 21.51 18.98 16.35 14.15 8.46
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 27.14 29.08 21.51 18.98 16.35 14.15
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.87 4.41 1.69 1.77 1.54 4.24
Earnings Per Share(Adj)-Unit Curr -0.87 4.41 1.69 1.77 1.54 4.24
Book Value 41.28 41.32 36.50 34.81 32.57 30.64
Book Value(Adj)-Unit Curr 41.28 41.32 36.50 34.81 32.57 30.64

Shareholding Pattern

  • Promoter Group

    22.51%

  • Public Share Holding

    77.49%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,945,000 13.27 2,945,000 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,049,500 9.24 2,049,500 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,994,500 22.51 4,994,500 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 8,216,547 37.03 8,208,707 47
Clearing Members 100 0.00 100 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 433,935 1.96 433,935 98
Foreign Non Institution Other 1,310,538 5.91 10,538 2
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,386,294 10.75 2,331,294 49
Individuals holding nominal share capital up to Rs. 1 lakh 4,848,714 21.85 4,598,687 20,901
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 17,196,128 77.49 15,583,261 21,098
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 22,190,628 100.00 20,577,761 21,106

Company Background

Vivo Bio Tech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vivo Bio Tech Ltd
  • BSE Code : 3920.0
  • ISIN : INE380K01017

  • Incorporation Year

    1987

  • Registered Office

    Survey #349/A Pregnapur Vlge
    , Gajel,
    Telangana-502311

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Bhavish Vijayvargiya

  • Auditor

    P Murali & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285,
    Domalguda,J B Apartments
    Mumbai - Hyderabad - 500 029

Vivo Bio Tech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vivo Bio Tech 12.70 53.01 52.57 -9.01 7.68
Abbott India 25,004.30 7,217.19 6,929.05 32.91 43.78
Astrazeneca Phar 5,988.15 2,304.07 2,275.58 88.26 27.86
Glaxosmi. Pharma 2,404.80 3,932.76 3,790.20 38.42 58.17
Novartis India 1,834.75 393.10 354.33 46.33 15.94
Cipla 1,337.00 20,102.60 18,979.95 35.14 13.88
Bliss GVS Pharma 628.50 773.53 729.81 58.41 12.51
Amrutanjan Healt 487.65 520.13 502.55 26.12 24.16
Fermenta Biotec. 454.90 474.15 450.25 21.24 18.77
Guj. Themis Bio. 327.25 168.25 165.82 87.50 18.05
Ambalal Sarabhai 34.60 19.52 3.94 64.07 6.77